Dwight Owen
Clinical trials sponsored by Dwight Owen, explained in plain language.
-
New hope for tough lung cancers: early trial tests Dual-Attack therapy
Disease control Recruiting nowThis early-stage trial is testing a new combination of two immunotherapy drugs, PBF-1129 and nivolumab, for people with advanced non-small cell lung cancer that has returned or spread. The main goal is to find the safest dose and understand the side effects. Researchers also want…
Phase: PHASE1 • Sponsor: Dwight Owen • Aim: Disease control
Last updated Mar 18, 2026 14:42 UTC
-
New combo therapy tested to fight tough lung Cancer's return
Disease control Recruiting nowThis study is testing if a combination of two drugs can help control advanced small cell lung cancer that has returned or spread after initial treatment. It will involve about 56 adults whose cancer has progressed after standard chemo-immunotherapy. The goal is to see if adding a…
Phase: PHASE2 • Sponsor: Dwight Owen • Aim: Disease control
Last updated Mar 18, 2026 14:41 UTC
-
New drug duo tested in fight against tough lung cancers
Disease control Recruiting nowThis early-stage study is testing a new combination of two drugs, vismodegib and atezolizumab, for adults with advanced non-small cell lung cancer that has come back or spread. The main goal is to find the safest dose and understand the side effects of using these drugs together.…
Phase: PHASE1 • Sponsor: Dwight Owen • Aim: Disease control
Last updated Mar 16, 2026 15:26 UTC